PB1911: A COMPREHENSIVE EHEALTH IMPLEMENTTION GUIDE CONSTRUCTED ON A QUALITATIVE CASE STUDY ON BARRIERS AND FACILITATORS OF THE DIGITAL CARE PLATFORM CMYLIFE, FOR PATIENTS WITH CHR...

por Verweij, L., Smit, Y., Blijlevens, N., Hermens, R.
Publicado 2022

Biomarkers and non-invasive tests for gastrointestinal mucositis

por Kuiken, N. S. S., Rings, E. H. H. M., Blijlevens, N. M. A., Tissing, Wim J. E.
Publicado 2017

P1382: RUXOLITINIB USE IN A REAL WORLD ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE COHORT IN THE NETHERLANDS: A RETROSPECTIVE STUDY

por Van Der Wagen, L., van Dorp, S., Bellido Cassado, M., Verheij, F., Nijssen, K., van der Velden, W., Biswana, A., Blijlevens, N., Kuball, J.
Publicado 2022

Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

por Janssen, L., Frambach, S. J. C. M., Allard, N. A. E., Hopman, M. T. E., Schirris, T. J. J., Voermans, N. C., Rodenburg, R. J., Blijlevens, N. M. A., Timmers, S.
Publicado 2019

Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever

por Wardill, H. R., de Mooij, C. E. M., da Silva Ferreira, A. R., van de Peppel, I. P., Havinga, R., Harmsen, H. J. M., Tissing, W. J. E., Blijlevens, N. M. A.
Publicado 2021

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS s...

por Cremers, E. M. P., van Biezen, A., de Wreede, L. C., Scholten, M., Vitek, A., Finke, J., Platzbecker, U., Beelen, D., Schwerdtfeger, R., Volin, L., Harhalakis, N., Blijlevens, N., Nagler, A., Kröger, N., de Witte, T.
Publicado 2016

Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?

por Stienen, J. J. C., Ottevanger, P. B., Wennekes, L., van de Schans, S. A. M., Dekker, H. M., van der Maazen, R. W. M., van Krieken, J. H. J. M., Blijlevens, N. M. A., Hermens, R. P. M. G.
Publicado 2015

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

por van Rhee, K P, de Vroom, S L, van Hest, R M, van der Linden, P D, Tonino, S H, Molendijk, E, Mathôt, R A A, Blijlevens, N M A, Knibbe, C A J, Bruggemann, R J M, Geerlings, S E
Publicado 2022

Supporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra

por Wardill, H. R., de Mooij, C. E. M., Da Silva Ferreira, A. R., Havinga, H., Harmsen, H. J. M., van der Velden, W. J. F. M., van Groningen, L. F. J., Tissing, W. J. E., Blijlevens, N. M. A.
Publicado 2022

The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach

por van Leeuwen, S. J. M., Proctor, G. B., Staes, A., Laheij, A. M. G. A., Potting, C. M. J., Brennan, M. T., von Bültzingslöwen, I., Rozema, F. R., Hazenberg, M. D., Blijlevens, N. M. A., Raber-Durlacher, J. E., Huysmans, M. C. D. N. J. M.
Publicado 2023

The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer

por de la Court, J. R., Bruns, A. H. W., Roukens, A. H. E., Baas, I. O., van Steeg, K., Toren-Wielema, M. L., Tersmette, M., Blijlevens, N. M. A., Huis in ’t Veld, R. A. G., Wolfs, T. F. W., Tissing, W. J. E., Kyuchukova, Y., Heijmans, J.
Publicado 2022

Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation

por van Leeuwen, S. J. M., Proctor, G. B., Laheij, A. M. G. A., Potting, C. M. J., Smits, O., Bronkhorst, E. M., Hazenberg, M. D., Haverman, T. M., Brennan, M. T., von Bültzingslöwen, I., Raber-Durlacher, J. E., Huysmans, M. C. D. N. J. M., Rozema, F. R., Blijlevens, N. M. A.
Publicado 2021

Good manufacturing practice production of CD34(+) progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia

por de Jonge, P. K. J. D., van Hauten, P. M. M., Janssen, L. D., de Goede, A. L., Berrien-Elliott, M. M., van der Meer, J. M. R., Mousset, C. M., Roeven, M. W. H., Foster, M., Blijlevens, N., Hobo, W., Fehniger, T. A., Jansen, J. H., Schaap, N. P. M., Dolstra, H.
Publicado 2023